Evidence map›Paper›PMID 23613322›Full record

ArticlePrenatal diagnosis2013

Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing.

M A Allyse, L C Sayres, M Havard, J S King, H T Greely, L Hudgins, J Taylor, M E Norton, M K Cho, D Magnus and 1 more

Open access · greenAbstract read
In one paragraph

Article in Prenatal diagnosis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Identifying Strategies to Improve Shared Decision Making for Pregnant Patients' Decisions about Prenatal Genetic Screens and Diagnostic Tests.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Consenting for molecular diagnostics.Clinical chemistry · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.Journal of perinatology : official journal of the California Perinatal Association · 2014
    Article
  18. Noninvasive prenatal testing goes global.Science translational medicine · 2014
    Article
  19. Article
  20. Genomic testing reaches into the womb.Nature biotechnology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

M A AllyseCenter for Biomedical Ethics, Stanford University, Stanford, CA, USA. megand@stanford.edu
L C Sayres
M Havard
J S King
H T Greely
L Hudgins
J Taylor
M E Norton
M K Cho
D Magnus
K E Ormond
Stanford University · USDuke University · USEthics and Public Policy Center · USUniversity of California Hastings College of the Law · US

Funding

Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Center for Integration of Research on Genetics and EthicsP50HG003389 · NHGRI · STANFORD UNIVERSITY · PI CHO, MILDRED K. · 2004 to 2014
$9.9M
NCATS NIH HHS UL1 TR001085NCRR NIH HHS 1 U54 RR024374-01A1NCRR NIH HHS UL1 RR025744NHGRI NIH HHS P50 HG003389
6 · The paper itself

Abstract

objectiveThe goal of this study is to provide an ethical framework for clinicians and companies providing noninvasive prenatal testing using cell-free fetal DNA or whole fetal cells.

methodIn collaboration with a National Institutes of Health-supported research ethics consultation committee together with feedback from an interdisciplinary group of clinicians, members of industry, legal experts, and genetic counselors, we developed a set of best practices for the provision of noninvasive prenatal genetic testing.

resultsPrincipal recommendations include the amendment of current informed consent procedures to include attention to the noninvasive nature of new testing and the potential for a broader range of results earlier in the pregnancy. We strongly recommend that tests should only be provided through licensed medical providers and not directly to consumers.

conclusionPrenatal tests, including new methods using cell-free fetal DNA, are not currently regulated by government agencies, and limited professional guidance is available. In the absence of regulation, companies and clinicians should cooperate to adopt responsible best ethical practices in the provision of these tests.

Indexed as

DNAFemaleFetusGenetic TestingHealth PersonnelHumansInformed ConsentLaboratoriesNational Institutes of Health (U.S.)Practice Guidelines as TopicPregnancyPrenatal DiagnosisUnited StatesDNA

Identifiers

PMID23613322
PMCPMC4057377
OpenAlexW2109011325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.